Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Capital Employed (2017 - 2025)

Organogenesis Holdings has reported Return on Capital Employed over the past 9 years, most recently at 0.1% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.1% for Q4 2025, up 10.0% from a year ago — trailing twelve months through Dec 2025 was 0.1% (up 10.0% YoY), and the annual figure for FY2025 was 0.1%, up 10.0%.
  • Return on Capital Employed for Q4 2025 was 0.1% at Organogenesis Holdings, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Capital Employed for ORGO hit a ceiling of 0.32% in Q2 2021 and a floor of 0.06% in Q1 2025.
  • Median Return on Capital Employed over the past 5 years was 0.05% (2022), compared with a mean of 0.08%.
  • Biggest five-year swings in Return on Capital Employed: soared 51bps in 2021 and later dropped -19bps in 2022.
  • Organogenesis Holdings' Return on Capital Employed stood at 0.22% in 2021, then plummeted by -74bps to 0.06% in 2022, then crashed by -44bps to 0.03% in 2023, then crashed by -110bps to 0.0% in 2024, then surged by 3127bps to 0.1% in 2025.
  • The last three reported values for Return on Capital Employed were 0.1% (Q4 2025), 0.02% (Q3 2025), and 0.06% (Q2 2025) per Business Quant data.